Analysis of the Long-Lasting Antagonistic Effect of Caerulein on Amphetamine Hyperactivity in Rats
Open Access
- 1 January 1985
- journal article
- research article
- Published by Elsevier in The Japanese Journal of Pharmacology
- Vol. 38 (4) , 381-390
- https://doi.org/10.1254/jjp.38.381
Abstract
Caerulein (CLN), which is chemically related to cholecystokinin octapeptide (CCK-8) and produces a short-lasting pharmacological effect when adminitered peripherally, caused a long-lasting antagonistic effect on amphetamine (AMP) hyperactivity in rats when given in combination with haloperidol (HLP). Briefly, rats were treated with a combination of CLN (0.3-40 .mu.g/kg s.c.) and HLP (0.1 mg/kg s.c.) and exposed to AMP on the first day. The animals became less sensitive to AMP for 24 hr to about 2 weeks depending on the CLN dose, according to measurements of their ambulatory activities in an open field or with an Animex activity meter at low sensitivity. Examination of the properties of this long-lasting effect revealed that: (1) in animals treated with CLN and HLP, but without AMP on the first day, the susceptibility to AMP was not influenced on the next day; (2) in substitution experiments, the antagonistic effect of CLN could be reproduced by higher doses of CCK-8 (160 .mu.g/kg) but not by nonsulfated CLN; (3) in the regimen of the treatment schedule, HLP could be replaced by chlorpromazine or sulpiride, but not by .alpha.-blocking agents like phenoxybenzmine or yohimbine; (4) apomorphine, nomifensine and tranylcypromine could not substitue for AMP. Thus, injection of CLN together with HLP and AMP on the first day might be necessary to produce the long-lasting anti-AMP effect. The possible mechanism of the is CLN effect is discussed.This publication has 36 references indexed in Scilit:
- Long-lasting reduction of amphetamine-induced hyperactivity in rats after combined administration of caerulein with haloperidolEuropean Journal of Pharmacology, 1984
- Antipsychotic Effects of Ceruletide (Caerulein) on Chronic SchizophreniaArchives of General Psychiatry, 1982
- Cholecystokinin appears to have antipsychotic propertiesProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1982
- Central depressant effects of caerulein and cholecystokinin octapeptide (CCK-8) differ from those of diazepam and haloperidolNeuropharmacology, 1981
- Analgesia and ptosis caused by caerulein and cholecystokinin octapeptide (CCK-8)Neuropharmacology, 1980
- Interactions between d-Ala-Met-enkephalin, A10 dopaminergic neurones, and spontaneous behaviour in the ratBehavioural Brain Research, 1980
- Species specificity of cholecystokinin in gut and brain of several mammalian species.Proceedings of the National Academy of Sciences, 1978
- Cholecystokinin and its COOH-terminal octapeptide in the pig brain.Proceedings of the National Academy of Sciences, 1977
- Immunochemical evidence of cholecystokinin-like peptides in brainNature, 1976
- New peptide in the vertebrate CNS reacting with antigastrin antibodiesNature, 1975